Ascendis Pharma A/s logo

Ascendis Pharma A/s (ASND)

$142.67

Ascendis Pharma A/s (ASND) Share Price Forecast
Currently 20 wall-street analysts regularly analyze the financials of Ascendis Pharma A/s on a frequent basis to provide recommendations along with target share price. 20 analysts offering 12-month price forecasts for Ascendis Pharma A/s (ASND) have a share price target of $196.35. This median of share price forecast represents a 37.63% upside from the latest price of $142.67 as on 05.10.24.

Ascendis Pharma A/s (ASND) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Ascendis Pharma A/s (ASND) share price will touch around $196.35 in next 12-months.
Ascendis Pharma A/s (ASND) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Ascendis Pharma A/s's share price and its median forecast price. As on 05.10.24, the difference is -25.34%

Ascendis Pharma A/s (ASND): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Ascendis Pharma A/s (ASND) Share Price : Analyst Recommendation
Based on 20 analysts tracking and researching Ascendis Pharma A/s (ASND) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
8
8
8
Outperform
8
8
8
Hold
4
4
4
Underperform
0
0
0
Sell
0
0
0
Ascendis Pharma A/s (ASND) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Ascendis Pharma A/s (ASND) is $196.35, offered by 20 analysts offering 12-month price forecasts.

Ascendis Pharma A/s (ASND) has a maximum of 0.38 upside potential, based on 20 analysts offering 12-month price forecasts.

Based on 20 analysts tracking and researching Ascendis Pharma A/s (ASND), 80% have a buy recommendation. Remaining 20% have either sell or hold recommendations.

The latest share price of Ascendis Pharma A/s (ASND) is $142.67 as of 05/10/2024.

16 of total 20 analysts offering stock ratings for Ascendis Pharma A/s ASND have recommended buy rating.